Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

Pfizer faces stagnant revenue and patent cliffs. Learn why I downgraded PFE stock to Strong Sell despite a 24.7% YoY growth ...

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...

The company is actively ... Additionally, Pfizer’s financial outlook appears promising, particularly with the potential for improved pricing and cash flow for its Paxlovid product.

Scroll through the chart ... flow increases and immune cells rush to the scene. This can result in pain, redness, or swelling at the injection site. The reaction is more common after Pfizer's ...

A look at the shareholders of Pfizer Inc. (NYSE:PFE) can tell us which group is most powerful. The group holding the most number of shares in the company ... In the chart below, we zoom in ...